Novofine Autocover Safety Needle Versus BD Safety Glide

Completed · Phase 4

Conditions studied: Diabetes, Healthcare Professionals, Delivery Systems

In brief

This trial is conducted in the United States of America (USA). The aim of this trial is to examine whether nurses prefer to use the NovoFine® Autocover Needle or the BD Safety Glide (TM) Syringe (only) in a hospital setting. The number of needle stick injuries will also be evaluated and whether these hospital nurses prefer the safety features of the NovoFine® Autocover Needle versus those of the BD Safety Glide (TM) Syringe. The identified hospital nurses will evaluate the two types of needles during standard administration of insulin to patients being treated for diabetes.

Key facts

Study ID

NCT00121355

Run by

Novo Nordisk A/S

People needed

83

Starts

2005-07-01

Expected to finish

2006-06-01

Last updated by the study team

2016-10-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Hospital nurses with prior injection training without an infectious blood borne disease

Where it is running

• Novo Nordisk Investigational Site — Plainsboro, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.